Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA-7 in human hepatocellular carcinoma cells

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107

Balogh, 2016, Hepatocellular carcinoma: a review, J Hepatocell Carcinoma, 3, 41, 10.2147/JHC.S61146

Levine, 2008, Autophagy in the pathogenesis of disease, Cell, 132, 27, 10.1016/j.cell.2007.12.018

Mizushima, 2008, Autophagy fights disease through cellular self-digestion, Nature, 451, 1069, 10.1038/nature06639

Puri, 2014, Autophagy modulation as a potential therapeutic target for liver diseases, J Clin Exp Hepatol, 4, 51, 10.1016/j.jceh.2014.04.001

Kumar, 2015, Targeting autophagy to overcome drug resistance in cancer therapy, Future Med Chem, 7, 1535, 10.4155/fmc.15.88

Du, 2012, Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells, Oncol Rep, 27, 143

Jung, 2010, mTOR regulation of autophagy, FEBS Lett, 584, 1287, 10.1016/j.febslet.2010.01.017

Bupathi, 2015, Hepatocellular carcinoma: Where there is unmet need, Mol Oncol, 9, 1501, 10.1016/j.molonc.2015.06.005

Wang, 2014, mTOR in viral hepatitis and hepatocellular carcinoma: Function and treatment, Biomed Res Int, 2014, 735672

Inamura, 2017, Diagnostic and therapeutic potential of MicroRNAs in lung cancer, Cancers (Basel), 9, 10.3390/cancers9050049

Cătană, 2017, Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma, Oncotarget, 8, 29519, 10.18632/oncotarget.15706

Faller, 2008, MicroRNA biogenesis: There's more than one way to skin a cat, Biochim Biophys Acta, 1779, 663, 10.1016/j.bbagrm.2008.08.005

Yao, 2014, Biomarker-based MicroRNA therapeutic strategies for hepatocellular carcinoma, J Clin Transl Hepatol, 2, 253

Horsham, 2015, Clinical potential of microRNA-7 in cancer, J Clin Med, 4, 1668, 10.3390/jcm4091668

Kalinowski, 2014, microRNA-7: A tumor suppressor miRNA with therapeutic potential, Int J Biochem Cell Biol, 54, 312, 10.1016/j.biocel.2014.05.040

Zhang, 2014, MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells, Biochem Biophys Res Commun, 443, 1078, 10.1016/j.bbrc.2013.12.095

Xiong, 2011, MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2, Int J Biol Sci, 7, 805, 10.7150/ijbs.7.805

Luo, 2015, MicroRNA-7 inhibits the malignant phenotypes of non-small cell lung cancer in vitro by targeting Pax6, Mol Med Rep, 12, 5443, 10.3892/mmr.2015.4032

Chang, 2015, MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway, Oncotarget, 6, 24017, 10.18632/oncotarget.4447

Fang, 2012, MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma, Hepatology, 55, 1852, 10.1002/hep.25576

Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262

Xie, 2014, miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression, Oncol Rep, 31, 1715, 10.3892/or.2014.3052

Bitto, 2014, P62/SQSTM1 at the interface of aging, autophagy, and disease, Age (Dordr), 36, 9626, 10.1007/s11357-014-9626-3

Zhu, 2010, Systemic treatment of hepatocellular carcinoma: Dawn of a new era?, Ann Surg Oncol, 17, 1247, 10.1245/s10434-010-0975-6

Gandellini, 2017, microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies, Semin Cancer Biol, 10.1016/j.semcancer.2017.03.005

Denaro, 2014, Non coding RNAs in head and neck squamous cell carcinoma (HNSCC): A clinical perspective, Anticancer Res, 34, 6887

Karagonlar, 2015, Targeting c-Met in cancer by MicroRNAs: Potential therapeutic applications in hepatocellular carcinoma, Drug Dev Res, 76, 357, 10.1002/ddr.21274

Luo, 2016, PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression, Autophagy, 12, 1355, 10.1080/15548627.2015.1034405

Tian, 2015, Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis, Cell Death Differ, 22, 1025, 10.1038/cdd.2014.201

Huang, 2015, SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway, Cancer Lett, 358, 180, 10.1016/j.canlet.2014.12.036

Wang, 2014, Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway, Toxicology, 326, 9, 10.1016/j.tox.2014.09.010

Lan, 2014, Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224, Hepatology, 59, 505, 10.1002/hep.26659

Gozuacik, 2017, Autophagy-Regulating microRNAs and cancer, Front Oncol, 7, 65, 10.3389/fonc.2017.00065

Liu, 2017, The role of autophagy in hepatocellular carcinoma: Friend or foe, Oncotarget

He, 2015, MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway, Oncotarget, 6, 28867, 10.18632/oncotarget.4814

Tazawa, 2012, Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis, Int J Cancer, 131, 2939, 10.1002/ijc.27589